Table 1.
First author | Design | Yr | Country | Ethnicity |
Case/control |
Genotyping | HWE | |||
n | Arg/Arg | Arg/Pro | Pro/Pro | |||||||
Yu et al[38] | HCC | 1999 | China | Asian | 80/328 | 28/112 | 35/141 | 17/75 | PCR-RFLP | 0.02 |
Anzola et al[36] | HCC | 2003 | Spain | Caucasian | 97/111 | 46/65 | 47/42 | 4/4 | PCR-SSCP | 0.38 |
Leveri et al[35] | PCC | 2004 | Italy | Caucasian | 86/254 | 46/122 | 33/113 | 7/19 | PCR-RFLP | 0.30 |
Zhu et al[31] | HCC | 2005 | China | Asian | 469/567 | 135/197 | 252/284 | 82/86 | PCR-RFLP | 0.32 |
Ezzikouri et al[30] | PCC | 2007 | Morocco | Caucasian | 96/222 | 52/129 | 31/79 | 13/14 | PCR-RFLP | 0.69 |
Yoon et al[29] | HCC | 2008 | Korea | Asian | 287/296 | 110/124 | 111/135 | 66/37 | PCR-RFLP | 0.98 |
HCC: Hospital-based case-control; PCC: Population-based case-control; PCR-RFLP: Polymerase chain reaction-restriction fragment length polymorphism; PCR-SSCP: Single strand conformation polymorphism analysis of polymerase chain reaction products; HWE: Hardy-Weinberg equilibrium of genotypes in control group. χ2-test is used, if P > 0.05, frequencies of genotypes in control group was in Hardy-Weinberg equilibrium.